Brouard A, Heaulme M, Leyris R, Pelaprat D, Gully D, Kitabgi P, Le Fur G, Rostene W
Institut National de la Santé et de la Recherche Médicale, Unité 339, Hôpital Saint Antoine, Paris, France.
Eur J Pharmacol. 1994 Mar 3;253(3):289-91. doi: 10.1016/0014-2999(94)90204-6.
In rat striatal slices, the increase (114 +/- 11%) in K(+)-evoked [3H]dopamine release induced by neurotensin (10 nM) was antagonized by 2-[(1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl) carboxylamino]tricyclo(3.3.1.1.3.7)decan-2-carboxylic acid (SR 48692, IC50 = 1.2 +/- 0.11 nM). SR 48692 (100 nM) also suppressed the neurotensin (10 nM)-induced increase (47%) in K(+)-evoked [3H]dopamine release in primary cultures of fetal rat mesencephalic cells. These results further characterize SR 48692 as a potent antagonist of neurotensin receptors in the rat.
在大鼠纹状体切片中,神经降压素(10 nM)诱导的K⁺诱发的[³H]多巴胺释放增加(114±11%)被2-[(1-(7-氯-4-喹啉基)-5-(2,6-二甲氧基苯基)吡唑-3-基)羧基氨基]三环(3.3.1.1.3.7)癸烷-2-羧酸(SR 48692,IC50 = 1.2±0.11 nM)拮抗。SR 48692(100 nM)还抑制了神经降压素(10 nM)诱导的胎鼠中脑细胞原代培养物中K⁺诱发的[³H]多巴胺释放增加(47%)。这些结果进一步将SR 48692表征为大鼠中神经降压素受体的强效拮抗剂。